BARCLAYS PLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 70 filers reported holding HUMACYTE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$70
-65.5%
23,788
-66.4%
0.00%
Q2 2023$203
+49.3%
70,843
+60.1%
0.00%
Q1 2023$136
+115.9%
44,252
+47.0%
0.00%
Q4 2022$63
-99.9%
30,107
+99.8%
0.00%
Q3 2022$49,0000.0%15,071
-0.9%
0.00%
Q2 2022$49,000
-52.4%
15,208
+4.4%
0.00%
Q1 2022$103,00014,5610.00%
Other shareholders
HUMACYTE INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders